EPCAM is a cell-adhesion molecule that has been associated with cell signaling, proliferation, differentiation, migration and metastasis[53] and used as a marker of both primary tumors and circulating tumor cells for patients with breast cancers and other endothelium-derived tumors[54,55]. This evidence concerns the gene EPCAM and breast carcinoma.